Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Retinal Pathology in Eye Diseases Using High Resolution Optical Coherence Tomography (High-Res-OCT)

NCT05130385 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT05130385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05130385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Retinal Pathology in Eye Diseases Using High Resolution Optical Coherence Tomography (High-Res-OCT)
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2021
Completion date
November 30, 2023
Enrollment
550 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema, diabetic retinopathy, glaucoma, hypertensive retinopathy, macular degeneration, macular disease, macular edema, optic nerve diseases, retinal artery occlusion, retinal detachment, retinal disease, retinal dystrophy, retinal edema, retinal neovascularization, retinal vein occlusion, uveitis